Supreme Cannabis' 7ACRES Facility Approved for Additional 50,000 Square Feet of Production Capacity

• Licensed space at 7ACRES increases to 230,000 sqft.
• Target annual production capacity is estimated to increase by 28% to approximately 33,580kg.
• Supreme Cannabis expects to submit additional rooms for Health Canada approval in the near term.

TORONTO , May 13, 2019 /CNW/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (FIRE.TO) (SPRWF) (53S1.F) today announced that its wholly-owned subsidiary, 7ACRES, has obtained Health Canada approval for five additional flowering rooms totalling 50,000 sqft of additional production space at its facility in Kincardine, Ontario .

Total flowering room space at 7ACRES increases from 180,000 sqft to 230,000 sqft and 7ACRES' annual production capacity estimate increases from approximately 26,250kg to 33,580kg. As noted previously, Supreme Cannabis expects to realize further production efficiencies following the licensing of all 25 flowering rooms, whereby 7ACRES' potential capacity is anticipated to reach approximately 50,000kg.

"With five more flowering rooms at 7ACRES now approved by Health Canada, the finish line is in sight," said John Fowler , President and Founder of Supreme Cannabis. "As 7ACRES continues to work towards full production capacity, we are excited to fulfil demand for our high-end cannabis from enthusiasts coast-to-coast."

About Supreme Cannabis

The Supreme Cannabis Company, Inc., is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the Company has emerged as one of the world's fastest-growing, premium plant driven-lifestyle companies by effectively deploying capital, with an emphasis on disciplined growth and high-quality products.

Supreme Cannabis' portfolio includes 7ACRES, its wholly-owned subsidiary and multi-award-winning brand; Cambium Plant Sciences, a plant genetics and cultivation IP company; Medigrow Lesotho, a cannabis oil producer located in southern Africa ; and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada.

Supreme trades as FIRE on the Toronto Stock Exchange (FIRE.TO), SPRWF on the OTC Exchange in the United States (SPRWF) and 53S1 on the Frankfurt Stock Exchange (53S1.F). Follow us on Instagram, Twitter, Facebook and YouTube.

We simply grow better.

Forward-Looking Information

Certain statements made in this press release may constitute forward-looking information under applicable securities laws. These statements may relate to anticipated events or results and include, but are not limited to, the estimated annual production capacity at 7ACRES' facility in Kincardine, Ontario , the Company's submission for additional flowering rooms for Health Canada approval in the near term and other statements that are not historical facts. Particularly, information regarding our expectations of future results, targets, performance achievements, prospects or opportunities is forward-looking information. Often, but not always, forward-looking statements can be identified by the use of forward-looking terminology such as "may", "will", "expect", "believe", "estimate", "plan", "could", "should", "would", "outlook", "forecast", "anticipate", "foresee", "continue" or the negative of these terms or variations of them or similar terminology. Forward-looking statements are current as of the date they are made and are based on applicable estimates and assumptions made by us at the relevant time in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we believe are appropriate and reasonable in the circumstances. However, we do not undertake to update any such forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable securities laws in Canada . There can be no assurance that such estimates and assumptions will prove to be correct.  Many factors could cause our actual results, level of activity, performance or achievements or future events or developments to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the factors discussed in the "Risk Factors" section of the Company's Annual Information Form dated October 2, 2018 ("AIF"). A copy of the AIF and the Company's other publicly filed documents can be accessed under the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com. The Company cautions that the list of risk factors and uncertainties described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking information and are cautioned not to place undue reliance on such information.